DuPont de Nemours, Inc. DD
At closeNov 4, 2026, 4:33 PM EST
After hours · Nov 4, 4:33 PM ET
- YTD
- +24.98%
- 1 year
- +33.06%
- Market cap
- 19.99B
- Revenue (ttm)
- 6.99B
- Profit margin
- 0.79%
- EPS (ttm)
- 2.87
- Shares out
- 132.61M
- P/E ratio
- 52.52
- Forward P/E
- 18.75
- Dividend
- 2.40 (1.70%)
- Ex-dividend date
- Nov 29, 2026
- YTD return
- +24.98%
- 1-year return
- +33.06%
- Volume
- 2.55M
- Avg volume
- 1.09M
- Open
- 155.24
- Previous close
- 153.46
- Day's range
- 150.73 – 155.96
- 52-week range
- 111.15 – 157.98
- Beta
- 1.09
- Analysts
- Buy
- Price target
- 167.29 (+11.0%)
- Earnings date
- Feb 9, 2027
5D +12.07 (+8.65%)
Key statistics
- Enterprise value
- 22.27B
- PEG ratio
- 1.72
- Price / sales
- 2.86
- Price / book
- 1.48
- Dividend yield
- 1.70%
- Payout ratio
- 81.45%
- Revenue growth
- 4.00%
- Free cash flow
- 1.84B
- Total cash
- 1.74B
- Total debt
- 3.18B
- Return on equity
- 1.79%
- Short % of float
- 3.95%
- 50-day average
- 132.61
- 200-day average
- 138.62
Analyst view
Consensus: buy
- Target (low)
- 145.00
- Target (mean)
- 167.29
- Target (high)
- 186.00
- Strong buy3
- Buy11
- Hold4
- Sell0
- Strong sell0
Next earnings
Feb 9, 2027
Expected Feb 9, 2027. Consensus EPS estimate 1.89.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 9, 2027 | Dec 30, 2026 | 1.87 | — | — | — |
| Nov 3, 2026 | Sep 30, 2026 | 1.87 | 2.09 | +0.22 | +11.76% |
| Aug 4, 2026 | Jun 30, 2026 | 1.76 | 1.88 | +0.12 | +6.82% |
| May 5, 2026 | Mar 31, 2026 | 0.4881 | 1.65 | +1.16 | +238.05% |
| Feb 10, 2026 | Dec 31, 2025 | 1.29 | 1.38 | +0.09 | +6.98% |
| Nov 6, 2025 | Sep 30, 2025 | 0.4656 | 3.27 | +2.80 | +602.32% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 4, 2026 | Barclays | main | Overweight | Overweight |
| Nov 3, 2026 | Fermium Research | main | Buy | Buy |
| Oct 15, 2026 | RBC Capital | main | Outperform | Outperform |
| Oct 13, 2026 | Barclays | init | — | Overweight |
| Oct 9, 2026 | JP Morgan | down | Overweight | Neutral |
| Oct 7, 2026 | Citigroup | main | Buy | Buy |
About DuPont de Nemours, Inc.
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors. It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the company offers engineered products and integrated solutions for the non-residential, residential, and repair-and-remodel construction markets, includes TYVEK house wrap, STYROFOAM insulation, and CORIAN solid surface. Further, it engages in the design and production of engineered components, systems, and process solutions used in OEM and operational applications, such as automotive, aerospace, printing, and packaging. Additionally, the company offers Vespel shapes and parts, MOLYKOTE specialty lubricants, BETAFORCE and BETASEAL structural adhesives, and Cyrel flexographic printing plates. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Country
- United States
- Website
- dupont.com
News
UBS Maintains Buy on DuPont de Nemours, Raises Price Target to $182
Citigroup Maintains Buy on DuPont de Nemours, Raises Price Target to $176
Barclays Maintains Overweight on DuPont de Nemours, Raises Price Target to $176
DuPont de Nemours Q3 Earnings Call Highlights
Why DuPont Stock Trounced the Market on Tuesday
DuPont de Nemours, Inc. (DD) Q3 2026 Earnings Call Transcript Fermium Research Maintains Buy on DuPont de Nemours, Raises Price Target to $160
Fabrinet, EverQuote, Lattice Semiconductor, Fiserv And Other Big Stocks Moving Higher On Tuesday
DuPont Raises Outlook As Order Book Climbs and AI Cuts Development Time
DD Q3 Earnings Beat on Organic Growth, Raises 2026 Outlook
Your note
Sign in to keep a note on DD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BREEN EDWARD D. | Director | Stock Gift | Aug 16, 2026 | 91,493 |
| CURTIN TERRENCE R | Director | Stock Award(Grant) | Aug 28, 2025 | 38,466 |
| DU PONT ELEUTHERE I | Director | Stock Award(Grant) | May 20, 2026 | 42,371 |
| FRANZEN ANTONELLA B | Chief Financial Officer | Stock Award(Grant) | Feb 19, 2026 | 70,360 |
| HOOVER ERIK THOMAS | General Counsel | Stock Award(Grant) | Feb 19, 2026 | 117,274 |
| KEMP JON D | Officer | Stock Award(Grant) | Feb 20, 2025 | 152,085 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 7.88% | 10,637,868 | 1.60B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.62% | 8,935,728 | 1.35B | Jun 29, 2026 |
| State Street Corporation | 5.15% | 6,949,792 | 1.05B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.74% | 6,405,233 | 965.78M | Jun 29, 2026 |
| Invesco Ltd. | 2.81% | 3,792,235 | 571.79M | Jun 29, 2026 |
| Geode Capital Management, LLC | 2.77% | 3,747,286 | 565.02M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.21% | 4,338,275 | 654.13M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.62% | 3,541,437 | 533.98M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.32% | 3,132,642 | 472.34M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 1.47% | 1,985,080 | 299.31M | Jun 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.33% | 1,799,175 | 271.28M | Sep 29, 2026 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.30% | 1,755,011 | 264.62M | Sep 29, 2026 |
